Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Cti Biopharma Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 119 | 1 | 133 | +15 |
| Shares | 88.5M | 8.10K | 97.7M | +9.19M (+10.4%) |
| Value | $510.1M | $48.0K | $554.7M | +$44.6M (+8.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held Cti Biopharma Corp at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (12)
Institutions that held Cti Biopharma Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fairmount Funds Management LLC | 2,245,891 | $13.4M |
| RTW Investments, LP | 471,630 | $2.82M |
| Balyasny Asset Management LLC | 102,333 | $611.0K |
| Virtu Financial LLC | 97,805 | $584.0K |
| Belvedere Trading LLC | 52,310 | $337.0K |
| Caxton Associates LP | 55,530 | $332.0K |
| Bayesian Capital Management, LP | 52,200 | $312.0K |
| Caption Management, LLC | 29,000 | $173.0K |
| XTX Topco Ltd | 14,669 | $88.0K |
| BDO Wealth Advisors, LLC | 2,000 | $12.0K |
| Parallel Advisors, LLC | 29 | $0 |
| Sound Income Strategies, LLC | 20 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Cti Biopharma Corp at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Dorsey Wright & Associates | 8,100 | $48.0K |